Tag: Plaque reduction

Studies show that while statins begin to reduce plaque inflammation within weeks, measurable plaque volume reduction often requires months or even years of consistent, high-intensity therapy. The overall timeframe for statin benefits on plaque depends on a complex interplay of factors, including dosage, treatment adherence, and individual patient health.

Over 92 million adults in the United States take statins to manage their cholesterol and reduce cardiovascular risk. Beyond their well-known role in lowering “bad” cholesterol, a key question for many is, *do statins reduce plaque in the heart*? The answer is more complex and compelling than a simple yes or no, involving both plaque stabilization and measurable, though often modest, regression.